A detailed history of Dimensional Fund Advisors LP transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,069,592 shares of IOVA stock, worth $16.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,069,592
Previous 2,265,555 8.65%
Holding current value
$16.8 Million
Previous $18.2 Million 6.96%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$7.28 - $11.9 $1.43 Million - $2.33 Million
-195,963 Reduced 8.65%
2,069,592 $19.4 Million
Q2 2024

Aug 09, 2024

SELL
$7.78 - $14.19 $4.71 Million - $8.6 Million
-605,943 Reduced 21.1%
2,265,555 $18.2 Million
Q1 2024

May 10, 2024

SELL
$7.59 - $17.47 $4.9 Million - $11.3 Million
-645,489 Reduced 18.35%
2,871,498 $42.6 Million
Q4 2023

Feb 07, 2024

SELL
$3.3 - $8.89 $1.52 Million - $4.1 Million
-461,398 Reduced 11.6%
3,516,987 $28.6 Million
Q3 2023

Nov 09, 2023

BUY
$4.44 - $8.79 $8.35 Million - $16.5 Million
1,881,382 Added 89.72%
3,978,385 $18.1 Million
Q2 2023

Aug 09, 2023

BUY
$5.36 - $9.06 $3.15 Million - $5.33 Million
587,770 Added 38.94%
2,097,003 $14.8 Million
Q1 2023

May 12, 2023

SELL
$5.53 - $8.22 $791,497 - $1.18 Million
-143,128 Reduced 8.66%
1,509,233 $9.22 Million
Q4 2022

Feb 09, 2023

SELL
$5.62 - $10.0 $57,054 - $101,520
-10,152 Reduced 0.61%
1,652,361 $10.6 Million
Q3 2022

Nov 10, 2022

BUY
$9.53 - $13.11 $3.96 Million - $5.44 Million
415,153 Added 33.28%
1,662,513 $15.9 Million
Q2 2022

Aug 12, 2022

BUY
$6.38 - $18.33 $465,076 - $1.34 Million
72,896 Added 6.21%
1,247,360 $13.8 Million
Q1 2022

May 13, 2022

BUY
$12.38 - $19.1 $3.59 Million - $5.54 Million
289,983 Added 32.79%
1,174,464 $19.6 Million
Q4 2021

Feb 09, 2022

BUY
$16.55 - $27.63 $9.16 Million - $15.3 Million
553,559 Added 167.28%
884,481 $16.9 Million
Q3 2021

Nov 12, 2021

BUY
$20.35 - $26.63 $3.19 Million - $4.17 Million
156,628 Added 89.86%
330,922 $8.16 Million
Q2 2021

Aug 12, 2021

SELL
$16.33 - $33.07 $275,258 - $557,427
-16,856 Reduced 8.82%
174,294 $4.54 Million
Q1 2021

May 14, 2021

BUY
$28.67 - $52.59 $1.5 Million - $2.76 Million
52,425 Added 37.79%
191,150 $6.04 Million
Q4 2020

Feb 25, 2021

BUY
$28.04 - $50.26 $3.89 Million - $6.97 Million
138,725 New
138,725 $6.44 Million

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.28B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.